Stenting for symptomatic vertebral artery stenosis
Neurology2017Vol. 89(12), pp. 1229–1236
Citations Over TimeTop 1% of 2017 papers
Hugh S. Markus, Susanna C. Larsson, Wilhelm Küker, Ursula G. Schulz, Ian Ford, Peter M. Rothwell, Andrew Clifton, VIST Investigators, Hugh Markus, Peter M. Rothwell, Andrew Clifton, John Bamford, Gavin Young, Thompson Robinson, Wilhelm Küker, Ursula G. Schulz, Ian Ford, Caroline Murphy, John Dennis, Kath Pasco, Ajay Bhalla, Kirsty Harkness, Susanna C. Larsson, Melina L Willson, Cara Hicks, Jennifer Lennon, Lindsay C. Davies, Usman Khan, Robert Hurford, Loes C.A. Rutten‐Jacobs, Peter Sandercock, Catriona Graham, Robin Sellar
Abstract
This study provides Class I evidence that for patients with symptomatic vertebral stenosis, angioplasty with stenting does not reduce the risk of stroke. However, the study lacked the precision to exclude a benefit from stenting.
Related Papers
- → Hemoglobin Levels Across the Pediatric Critical Care Spectrum: A Point Prevalence Study*(2018)8 cited
- → Effect of topical 0.05% cyclosporine A on corneal endothelium in patients with dry eye disease.(2013)9 cited
- → Prognostic value of proadrenomedullin in patients with COVID-19 pneumonia(2022)3 cited
- 效果热门在有干燥眼睛疾病的病人的角膜的内皮细胞层上的 0.05% cyclosporine A(2013)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)